Feed VISL
Summary
38 / 100 · Bulios Score
Valuation 100Growth 0Profitability 14Quality 15Debt 60Stability 47
What speaks for it
- It holds more cash than debt: $2.78M against $689.0K.
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 13% a year over the last 3 years.
- It missed profit estimates 7 times in the last 8 quarters.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
202120222023202420252026
Diluted EPS (USD)
202120222023202420252026
- Analyst estimate
Revenue fell by 4.2% a year over 5 years. Over the last 3 years it fell by 13% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $4.40M.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $2.78M
Debt $689.0K
Free cash flow over 12 months -$3.04M
Over the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 4
- Hold 0
- Sell 1
No analyst has published a price target.
80% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2024By product
The company reports no revenue by product.
By region
- North America 42%
- Europe 28%
- Rest of World 17%
- Asia 13%
- South America 0.1%
North America brings in 42% of revenue. Rest of World grew fastest, by 26% a year.
Segments in detail